SOUTH KOREA Trends and Developments
Trends and Developments Contributed by: Keum Nang Park, Eileen Jaiyoung Shin, Jeonghoon Hong and Soo Yeon Park Lee & Ko
Lee & Ko has become one of Korea’s premier full-service law firms, widely recognised for its leadership and outstanding success in every area of legal practice. As has been confirmed in numerous reviews conducted by Korea’s major media outlets, as well as ratings produced by international law firm rating services, Lee & Ko enjoys one of the highest levels of client sat- isfaction and a particularly excellent reputation
for the quality of the firm’s legal services. Lee & Ko’s healthcare practice group of more than 70 professionals focuses on providing legal servic- es expertly tailored to meet the needs of clients with specific concerns around healthcare and related matters, including pharma, bio, medical devices, food and beverage products, medical data with AI application, genome analysis, DTC, tobacco and cosmetics.
Authors
Keum Nang Park is the co-head of the healthcare and life sciences group at Lee & Ko and a leading expert in intellectual property law and pharmaceutical affairs law. She is a licensed
Eileen Jaiyoung Shin is a partner in Lee & Ko’s healthcare and life sciences practice group, specialising in corporate matters, commercial transactions and healthcare
pharmacist in both Western and Eastern medicine and holds a Master’s degree in Pharmacology. Her background enables her to effectively represent clients in complex, multi-jurisdictional litigation involving pharmaceuticals, medical devices and biotechnology. She has extensive experience advising on regulatory compliance, patent disputes, and market entry strategies for pharmaceutical companies, and her expertise has been widely recognised through government acknowledgement and numerous prestigious accolades.
regulatory compliance. She has extensive experience advising clients in the pharmaceutical, medical device, cosmetic, tobacco, and food industries on regulatory compliance, licensing and transactional matters. She provides strategic guidance on corporate governance and risk management in highly regulated sectors and regularly assists multinational clients with new drug pricing strategies, reimbursement policies and post- launch life cycle management, working closely with the firm’s market access practice. Her expertise extends to cross-border transactions and market entry strategies, ensuring clients align with evolving global compliance requirements.
295 CHAMBERS.COM
Powered by FlippingBook